Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials

Cheng MKW, Eseigbe MO, Orozco JH, Park S, Modrow MF, Fontil V, Pletcher MJ. Effectiveness of Mailed Patient Activation Letters for Blood Pressure Control: A[...]

Barjaktarevic I, Kuhn B. Correction: Letter to the Editor: An unspoken contributor to VILI in ARDS-asymmetry of lung injury. Intensive Care Med. 2025 Nov 4.[...]

Healy C, Campbell C, Hoffman K, Butler JJ, Opron K, Erb-Downward JR, Zhang WZ, Barjaktarevic I, Han MK, Kaner RJ, Curtis JL, Freeman CM, Barr[...]